SIX:NWRN
Newron Pharmaceuticals S.p.A. · SIX · Healthcare · CHF · FY for 2025
Figures on this page computed 2026-11-08 12:42 UTC
Last close
n/aCHF
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-69.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Safety is the furthest below its sector's middle: 0.26 against 0.52 on the market's range.
- Growth29.5%49 of 100, below its sector
- Returns on capital-33.0%18 of 100, below its sector
- Margins100.0%48 of 100, above its sector
- Price10.1x11 of 100, below its sector
- Safety0.7626 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.50x
Its own average over 10 years, 12.8M.
- Profit1.08x
Its own average over 10 years, -12.3M.
- Free cash flown/a
Its own average over 9 years, -14.7M.
- Debt1.27x
Its own average over 9 years, 30.0M.
- Pricen/a
Its own average over 0 years. Market data
Sales is furthest from its own average, at 1.50 times.
Sales is 1.50 times its own 10-year average; Profit is 1.08 times its own 10-year average; Debt is 1.27 times its own 9-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average1.50
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Profit against its own 10-year average1.08
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Free cash flow against its own 9-year averagen/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Debt against its own 9-year average1.27
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- CHF